当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:85.75亿  总市值:87.74亿
流通股本:2.06亿   总股本:2.11亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润1.98亿元,每股收益0.96元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益290425.49万元,未分配利润82149.17万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产550494.59万元,负债260069.10万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入2,270,177,811.51,619,063,344.91,055,549,087.12504,874,103.59
营业总成本1,900,882,004.661,383,328,088.18919,361,955.83465,236,626.83
营业利润236,817,376.92157,760,861.7278,476,846.7816,593,800.36
利润总额238,355,281.35157,832,706.4378,640,841.816,700,129.51
净利润197,930,034.58140,779,655.4168,918,893.516,536,169.84
其他综合收益22,673,517.3914,035,099.2912,837,511.63347,032.14
综合收益总额220,603,551.97154,814,754.781,756,405.1316,883,201.98
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计3,174,918,772.72,376,880,587.72,227,859,454.342,242,692,568.83
非流动资产合计2,330,027,122.572,306,622,057.72,144,790,659.772,078,750,166.16
资产总计5,504,945,895.274,683,502,645.44,372,650,114.114,321,442,734.99
流动负债合计1,260,187,291.81,210,004,419.41,136,910,737.461,211,266,462.66
非流动负债合计1,340,503,672.54751,777,802.32592,842,163.17546,855,693.07
负债合计2,600,690,964.341,961,782,221.721,729,752,900.631,758,122,155.73
归属于母公司股东权益合计2,877,877,144.942,704,179,683.132,621,241,196.552,543,858,967.16
股东权益合计2,904,254,930.932,721,720,423.682,642,897,213.482,563,320,579.26
负债和股东权益合计5,504,945,895.274,683,502,645.44,372,650,114.114,321,442,734.99
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计2,360,017,508.131,654,346,586.741,057,675,016.59474,799,584.5
经营活动现金流出小计1,978,057,249.821,495,338,546.22980,575,236.32446,474,098.49
经营活动产生的现金流量净额381,960,258.31159,008,040.5277,099,780.2728,325,486.01
投资活动现金流入小计29,357,419.5219,913,172.0416,778,889.08949,772.2
投资活动现金流出小计813,011,609.64199,118,409.29193,442,522.91120,462,037.34
投资活动产生的现金流量净额-783,654,190.12-179,205,237.25-176,663,633.83-119,512,265.14
筹资活动现金流入小计1,633,575,712.21605,040,019.79381,165,513.53165,645,972.06
筹资活动现金流出小计842,097,185.26568,561,561.84334,143,756.9105,667,376.89
筹资活动产生的现金流量净额791,478,526.9536,478,457.9547,021,756.6359,978,595.17
汇率变动对现金及现金等价物的影响7,845,113.984,215,590.655,893,201.64-425,949.69
现金及现金等价物净增加额397,629,709.1220,496,851.87-46,648,895.29-31,634,133.65
期末现金及现金等价物余额873,095,672.73495,962,815.48428,817,068.32443,831,829.96
最新报告期:2025-03-30
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
开源证券余汝意,聂媛媛1.311.772.252025-03-30
信达证券唐爱金1.191.501.902025-03-28
西部证券徐子悦,李梦园1.161.431.762025-03-28
海通证券周航,余文心,贺文斌1.191.70--2025-03-08
兴业证券孙媛媛1.171.44--2025-03-04
TOP↑